SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-108143
Filing Date
2021-08-20
Accepted
2021-08-20 16:01:45
Documents
13
Period of Report
2021-08-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125270d1_8k.htm   iXBRL 8-K 29110
2 EXHIBIT 3.1 tm2125270d1_ex3-1.htm EX-3.1 9929
  Complete submission text file 0001104659-21-108143.txt   218909

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA catb-20210819.xsd EX-101.SCH 3191
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE catb-20210819_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE catb-20210819_pre.xml EX-101.PRE 22714
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2125270d1_8k_htm.xml XML 3807
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 211193803
SIC: 2834 Pharmaceutical Preparations